Profile
Dr. Deleage has been a Director of Plexxikon, Inc. since April 1996.
He is a Founder and Managing Director of Alta Partners, a venture capital firm investing in information technologies and life science companies.
He was Managing Partner of Burr, Egan, Deleage & Co. in 1979.
He was a member of Sofinnova's initial team, a venture capital organization in Paris, and in 1976 formed Sofinnova, Inc. He is a Director of Rigel Pharmaceuticals, Inc. and Xcyte Therapies, Inc. In 1984, he was awarded the Ordre National du Merite and the Legion of Honor from the French government in 1993.
Dr. Deleage received a Master's Degree in Electrical Engineering from Ecole Superieurie d'Electricite and a Ph.D.
in Economics from the University of Paris in Sorbonne.
Former positions of Jean Deleage
| Companies | Position | End |
|---|---|---|
Alta Partners Management Co. LP
Alta Partners Management Co. LP Investment ManagersFinance Alta Partners invests in companies located in the United States. The firm focuses on life sciences and healthcare technology services sectors. It participates in seed, early and later stage capital transactions. It acts as the lead investor and takes a seat on board of directors. | Founder | 2011-04-30 |
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Director/Board Member | 2011-04-30 |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Director/Board Member | 2011-04-30 |
| ADOCIA | Director/Board Member | 2011-04-30 |
PamGene International BV
PamGene International BV Pharmaceuticals: MajorHealth Technology Provides biotechnology products for pharma and medical research | Director/Board Member | 2011-04-30 |
Training of Jean Deleage
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 23 |
|---|---|
Burr, Egan, Deleage & Co.
Burr, Egan, Deleage & Co. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Alta Partners Management Co. LP
Alta Partners Management Co. LP Investment ManagersFinance Alta Partners invests in companies located in the United States. The firm focuses on life sciences and healthcare technology services sectors. It participates in seed, early and later stage capital transactions. It acts as the lead investor and takes a seat on board of directors. | Finance |
Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Health Technology |
Xcyte Therapies, Inc.
Xcyte Therapies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Health Technology |
AGY Therapeutics, Inc.
AGY Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapies for diseases and disorders | Health Technology |
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Commercial Services |
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
PamGene International BV
PamGene International BV Pharmaceuticals: MajorHealth Technology Provides biotechnology products for pharma and medical research | Health Technology |
Nereus Pharmaceuticals, Inc.
Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapeutics for cancer, inflammatory, and infectious diseases | Commercial Services |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
Innate Pharma SA
Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
TorreyPines Therapeutics, Inc. /Old/
TorreyPines Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
U3 Pharma AG
U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services Researches and develops novel targeted therapeutics used for cancer treatment | Commercial Services |
PamGene BV
PamGene BV Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products and clinical settings | Health Technology |
Genedata AG
Genedata AG Packaged SoftwareTechnology Services Provides software solutions for biopharmaceutical R&D | Technology Services |
IDM Pharma, Inc.
IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | Health Technology |
Université de Paris IV Paris-Sorbonne
Université de Paris IV Paris-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
École supérieure d'électricité
École supérieure d'électricité Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
7TM A/S
7TM A/S BiotechnologyHealth Technology Operates as a biotech company that discovers and develops drugs | Health Technology |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products | Health Technology |
TPTX, Inc.
TPTX, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biopharmaceuticals | Commercial Services |
Adocia SA
Adocia SA Pharmaceuticals: MajorHealth Technology Manufactures novel therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases | Health Technology |
- Stock Market
- Insiders
- Jean Deleage
















